FDA.reportPublic FDA data

Rezlidhia 150 MG Oral Capsule

RxCUI
2623654
RxNorm name
Rezlidhia 150 MG Oral Capsule
Display name
Rezlidhia 150 MG Oral Capsule
Full name
Rezlidhia 150 MG Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:56

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
REZLIDHIAOLUTASIDENIBRigel Pharmaceuticals, Inc.4a0c7c8b-b95f-455d-9600-b7351e4397fe2025-11-05Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2623654

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
4a0c7c8b-b95f-455d-9600-b7351e4397feREZLIDHIA 150 MG Oral Capsule [PSN] · olutasidenib 150 MG Oral Capsule [Rezlidhia] [SBD] · Rezlidhia 150 MG Oral Capsule [SY]35These highlights do not include all the information needed to use REZLIDHIA safely and effectively. See full prescribing information for REZLIDHIA. REZLIDHIA ® (olutasidenib) capsules, for oral use Initial U.S. Approval: 202220251105